Secure Homomorphically Encrypted National Registry of COVID-19 Recovered Plasma Donors

项目摘要 FDA最近批准用恢复期血浆（CP）治疗10岁以下的重病患者， 新冠肺炎。有很多机构和医院已经实施了CP计划，但他们都面临着 找到足够和合适的捐助者的挑战。配套的制约，供给的不平衡 需求和隐私方面的问题对捐助者的参与提出了若干挑战。考虑多个 利益相关者（患者，捐赠者，医院），我们将开发基于多密钥同态的新算法 加密以保护患者和捐赠者的隐私，并具有简化注册的附加功能 流程，并对（从COVID-19中康复的患者的）血浆捐献进行优化。我们 致力于公益，并将免费提供代码/资源内开发的 这个项目的框架。如果我们成功了，我们的项目将为潜在的血浆建立一个安全的国家登记处。 捐赠者，并可能挽救许多生命。

PROJECT SUMMARY Treatment with convalescent plasma (CP) was recently approved by the FDA for seriously ill patients of COVID-19. There are many institutions and hospitals that have implemented CP programs, but they all face the challenge of finding sufficient and appropriate donors. The constraints of matching, imbalances in supply and demand, and privacy concerns pose several challenges to engage donors. Considering multiple stakeholders (patients, donors, hospitals), we will develop new algorithms based on multikey homomorphic encryption to protect the privacy of patients and donors, with additional functionality to simplify the registration process, and conduct optimization for plasma donation (of patients who recovered from COVID-19). We are dedicated to the public good and will make freely available the code / resources developed within the framework of this project. If we succeed, our project will build a secure national registry for potential plasma donors and may save many lives.